Patent: 5,650,503
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 5,650,503
Title: | Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals |
Abstract: | Proteinaceous products can be produced by transgenic animals having genetic constructs integrated into their genome. The construct comprises a 5\'-flanking sequence from a mammalian milk protein gene (such as beta-lactoglobulin) and DNA coding for a heterologous protein other than the milk protein (for example a serin protease such as alpha.sub.1 -antitrypsin or a blood factor such as Factor VIII or IX). The protein-coding DNA comprises at least one, but not all, of the introns naturally occurring in a gene coding for the heterologous protein. The 5\'-flanking sequence is sufficient to drive expression of the heterologous protein. |
Inventor(s): | Archibald; Alan Langskill (Edinburgh, GB), Clark; Anthony John (Lasswade, GB), Harris; Stephen (Edinburgh, GB), McClenaghan; Margaret (Edinburgh, GB), Simons; Jonathan Paul (Edinburgh, GB), Whitelaw; Christopher Bruce Alexander (Edinburgh, GB) |
Assignee: | PPL Therapeutics (Scotland) Limited (Edinburgh, GB6) |
Application Number: | 08/359,854 |
Patent Claims: | see list of patent claims |
Details for Patent 5,650,503
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Sign Up | 2008-11-11 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Sign Up | 2008-11-11 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Sign Up | 2008-11-11 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |